Social Media for Exploring Adverse Drug Events Associated with Multiple Sclerosis

dc.contributor.authorNawar, Nevine
dc.contributor.authorEl-Gayar, Omar
dc.contributor.authorAmbati, Loknath Sai
dc.contributor.authorBojja, Giridhar Reddy
dc.date.accessioned2021-12-24T17:57:09Z
dc.date.available2021-12-24T17:57:09Z
dc.date.issued2022-01-04
dc.description.abstractMultiple Sclerosis (MS) affects 400,000 people in the USA and almost 2.5 million people worldwide. There is no cure for MS. A variety of disease-modifying therapies are currently available. They aim to reduce disease activity that ultimately leads to disability. However, such drugs have adverse effects that vary widely among patients making the choice of a suitable drug particularly challenging. With the proliferation of social media, this research aims to understand the perspective of people with MS on social media (Twitter) in regard to Adverse Drug Events (ADEs) and to analyze ADEs as perceived by MS patients. This study helps in understanding ADEs associated with MS drugs and can further inform future medical research by highlighting and prioritizing additional clinical trials needed to better assess such adverse drug effects.
dc.format.extent10 pages
dc.identifier.doi10.24251/HICSS.2022.515
dc.identifier.isbn978-0-9981331-5-7
dc.identifier.urihttp://hdl.handle.net/10125/79851
dc.language.isoeng
dc.relation.ispartofProceedings of the 55th Hawaii International Conference on System Sciences
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectSocia Media and Healthcare Technology
dc.subjectadverse drug effects
dc.subjectmultiple sclerosis
dc.subjectsocial media
dc.subjecttwitter
dc.titleSocial Media for Exploring Adverse Drug Events Associated with Multiple Sclerosis
dc.type.dcmitext

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
0416.pdf
Size:
1.02 MB
Format:
Adobe Portable Document Format